This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Urinary Tract Infection (UTI) Treatment Market

Market Insights on Urinary Tract Infection (UTI) Treatment covering sales outlook, demand forecast & up-to-date key trends

Urinary Tract Infection (UTI) Treatment Market By Drug Class (Penicillin & Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides) Indication (Complicated Urinary Tract Infection), Distribution Channel (Hospital Pharmacies, Gynecology and Urology Clinics) & Region - Forecast 2019 - 2029

Urinary Tract Infection (UTI) Treatment Market – Key Research Findings

  1. Urinary tract infection treatment market size valuated in 2018 was ~US$ 10 Bn
  2. The UTI treatment market is anticipated to grow at a CAGR of ~2% over 2019-2029. 
  3. Europe is expected to remain the leading regional market for urinary tract infection treatment. 
  4. Leading companies operating in the UTI treatment market are focusing on expanding production facilities and establishing long-term distribution contracts with major local distribution companies, to stay competitive among their peers in the urinary tract infection market. 
  5. Quinolones, in terms of drug class, are projected to lead the way in urinary tract infection treatment market over the forecast period. 
Customize this Report

Let us know your requirement to get
100% FREE customization

Top 3 Factors Shaping the Urinary Tract Infection Treatment Market

  • Increasing UTI Prevalence to Drive the Urinary Tract Infection Treatment Market

    Urinary tract infection is more common in women compared to men due to their anatomy. Several women experience urinary tract infection more than once in their lifetime. According to certain studies, urinary tract infection affects approximately 150 million people globally. In addition, approximately 11% women visit one physician in a year for urinary tract infection treatment.

    Hormonal changes, improper personal hygiene, use of catheters, and other factors are some of the main causes of urinary tract infection. With an increase in the prevalence of urinary tract infection, the urinary tract infection treatment market is expected to witness significant growth in the coming years. 

  • Rising Demand for Antibiotics to Contribute to the Demand for Urinary Tract Infection Treatment

    Antibiotics are the only treatment options available for urinary tract infection. According to the severity of the infection, a wide range of antibiotics are prescribed. For instance, for uncomplicated urinary tract infection treatment, fluoroquinolones, trimethoprim/sulfamethoxazole, and aminoglycosides are prescribed as initial treatment.

    Similarly, for complicated urinary tract infection treatment cases, fluoroquinolones such as ciprofloxacin or ofloxacin are prescribed in case of less severe infection. Apart from these, loss of patent rights of branded drugs and the availability of cost-effective antibiotics from generic companies are among factors that are likely to spur the growth of the urinary tract infection treatment market. 

    Urinary Tract Infection (UTI) Treatment Market Download Report Brochure

  • Rising Use of Urinary Catheters and Other Drainage Devices Likely to Offer an Uptick to Urinary Tract Infection Treatment Market Growth 

    The rising incidence of chronic kidney diseases, such as bladder cancer and renal failure, has led to the increase usage of catheters and other drainage devices in patients. Patients using urinary catheters are more likely to acquire complicated UTI. According to World Health Organization (WHO), the risk of bacteriuria is approximately 5% per day for patients using urinary catheters and 40% suffer from nosocomial infections.

    Certain factors, such as prolonged duration of catheterisation, not receiving system therapy of antibiotics, bacterial colonisation in drainage bags, rapid fata underlying diseases, and others, are likely to result in catheter-associated urinary tract infection. Hence, increase in the usage of urinary catheters will foster the growth of the urinary tract infection treatment market. 

Urinary Tract Infection Treatment Market Structure Analysis

  • Key comapnies spearheading the comeptition landscape of the global UTI treatment market, such as Bayer AG, are focused on stregthening their R&D activties for the development of novel drug molecules. 
  • FMI analyses that a majority of leading players, for instance Allergan Plc, in urinary tract infection treatment market are also prioritizing strategic collaborations and acquisitions to achieve broader availability on market and tap the unmet needs of patients.
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Urinary Tract Infection Treatment: Antibiotics for the Management of Urinary Tract Infection

The Urinary Tract Infection (UTI) treatment market is anticipated to witness growth since antibiotics are the only treatment for the management of the same. Loss of patent rights by branded drugs and the emergence of branded generics and generic drugs are among factors that are likely to boost the urinary tract infection treatment market.

Market Set to Grow by 1.2X between 2019 and 2029

The urinary tract infection treatment market is expected to register considerable growth owing to the rising prevalence of urinary tract infections and increase in the number of hospital visits for urinary tract infection testing as well as treatment. Moreover, the high demand for antibiotics in urinary tract infection treatment and growth in the number of generic players is likely to propel the growth of the urinary tract infection treatment market.

Urinary Tract Infection (UTI) Treatment Market Download Report Brochure

Emerging Countries Foster New Growth Opportunities for the Urinary Tract Infection Treatment Market

Europe holds a prominent revenue share among other regions in the global urinary tract infection treatment market in 2019. However, developing countries, such as China, India, and South Korea, have witnessed growth in the urinary tract infection treatment market due to increasing awareness about urinary tract infection treatment and rising government initiatives for healthcare spending.

The Broader Perspective

Various manufacturers are engaged in strategic acquisitions and collaborations with different companies and distribution channels to increase the sales of their products and enhance their business operations.

How Growth will Unfold

The prevalence of UTI is increasing at an alarming rate. Improper use of disposable hygiene products for personal use, administration of catheters in urethra, sexual activity, menopause, and certain other factors are anticipated to boost the urinary tract infection treatment market. The growing demand for antibiotics and the low cost of generic drugs is also expected to spur the growth of the urinary tract infection treatment market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

UTI (URINARY TRACT INFECTION) TREATMENT MARKET TAXONOMY

The global urinary tract infection treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

By Drug Class

  • Penicillin & Combinations
  • Quinolones
  • Cephalosporin
  • Aminoglycoside Antibiotics
  • Sulphonamides (Sulfamethoxazole, Trimethoprim)
  • Azoles and Amphotericin B
  • Tetracycline (Doxycycline)
  • Nitrofurans (Nitrofurantoin)
  • Others

By Indication

  • Complicated Urinary Tract Infection
  • Uncomplicated Urinary Tract Infection

By Distribution Channel

  • Hospital Pharmacies
  • Gynecology and Urology Clinics
  • Drug Stores
  • Retail Pharmacies
  • Online Drug Stores

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

The urinary tract infections market is predicted to grow at 2% CAGR through 2032.

Asia Pacific urinary tract infections market holds the highest revenue potential.

The urinary tract infections market is expected to surpass US$ 10.29 Bn by 2032.

The urinary tract infections market size is anticipated to be over US$ 12.54 Bn in 2022.

Table of Content

1. Executive Summary

2. Market Overview

3. Key Market Trends

4. Key Success Factors

5. Global Urinary Tract Infection Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

    5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

    5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Favourable Incentive & Reimbursement Policies

        6.1.2. Increasing Consumption of Antibiotics per Capita

    6.2. Forecast Factors - Relevance & Impact

        6.2.1. Increase in Drug Resistance

        6.2.2. Patent Loss of Branded Drugs

        6.2.3. Government Regulations in Product Approval

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunity Analysis

7. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2014 - 2018

    7.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Drug Class, 2019 - 2029

        7.3.1. Penicillin and Combinations

            7.3.1.1. Amoxicillin 

            7.3.1.2. Amoxicillin and Clavulanate Potassium

            7.3.1.3. Others

        7.3.2. Quinolones 

            7.3.2.1. Ciprofloxaxin

            7.3.2.2. Levofloxaxin

            7.3.2.3. Nalidixic acid

            7.3.2.4. Norfloxacin

            7.3.2.5. Others

        7.3.3. Cephalosporin

            7.3.3.1. Ceftriaxone

            7.3.3.2. Cefuroxime

            7.3.3.3. Cefixime

            7.3.3.4. Cephalexin

        7.3.4. Aminoglycoside Antibiotics

            7.3.4.1. Amikacin

            7.3.4.2. Gentamicin

        7.3.5. Sulphonamides (Sulfamethoxazole +Trimethoprim)

        7.3.6. Azoles and Amphotericin B

        7.3.7. Tetracycline (Doxycycline)

        7.3.8. Nirtofurans (Nitrofurantoin)

        7.3.9. Other 

    7.4. Market Attractiveness Analysis By Drug Class

8. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Indication

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) and Analysis By Indication, 2014 - 2018

    8.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Indication, 2019- 2029

        8.3.1. Complicated Urinary Tract Infection 

        8.3.2. Uncomplicated Urinary Tract Infection

    8.4. Market Attractiveness Analysis By Indication

9. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Analysis By Distribution Channel, 2014 - 2018

    9.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Distribution Channel, 2019 - 2029

        9.3.1. Hospital Pharmacies

        9.3.2. Gynaecology and Urology Clinics

        9.3.3. Drug Stores

        9.3.4. Retail Pharmacies

        9.3.5. Online Drug Stores

    9.4.  Market Attractiveness Analysis By Distribution Channel

10. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) and Analysis By Region, 2014 - 2018

    10.3. Current Market Size (US$ Mn) and Analysis and Forecast By Region, 2019 - 2029

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. South Asia

        10.3.5. East Asia

        10.3.6. Oceania

        10.3.7. Middle East and Africa

    10.4. Market Attractiveness Analysis By Region

11. North America Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        11.3.1.  By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Drug Class

        11.3.3. By Indication

        11.3.4. By Distribution Channel

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Drug Class

        11.4.3. By Indication

        11.4.4. By Distribution Channel

    11.5. Drivers and Restraints - Impact Analysis

12. Latin America Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        12.3.1.  By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Rest of Latin America

        12.3.2. By Drug Class

        12.3.3. By Indication

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Drug Class

        12.4.3. By Indication

        12.4.4. By Distribution Channel

    12.5. Drivers and Restraints - Impact Analysis

13. Europe Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        13.3.1.  By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Russia

            13.3.1.8. Rest of Europe

        13.3.2. By Drug Class

        13.3.3. By Indication

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Drug Class

        13.4.3. By Indication

        13.4.4. By Distribution Channel

    13.5. Drivers and Restraints - Impact Analysis

14. South Asia Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        14.3.1.  By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Indonesia

            14.3.1.4. Malaysia

            14.3.1.5. Rest of South Asia

        14.3.2. By Drug Class

        14.3.3. By Indication

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Drug Class

        14.4.3. By Indication

        14.4.4. By Distribution Channel

    14.5. Drivers and Restraints - Impact Analysis

15. East Asia Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        15.3.1.  By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Drug Class

        15.3.3. By Indication

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Drug Class

        15.4.3. By Indication

        15.4.4. By Distribution Channel

    15.5. Drivers and Restraints - Impact Analysis

16. Oceania Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        16.3.1.  By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Drug Class

        16.3.3. By Indication

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Drug Class

        16.4.3. By Indication

        16.4.4. By Distribution Channel

    16.5. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

    17.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

        17.4.1.  By Country

            17.4.1.1. GCC Countries

            17.4.1.2. Turkey

            17.4.1.3. Northern Africa

            17.4.1.4. South Africa

            17.4.1.5. Rest of Middle East and Africa

        17.4.2. By Drug Class

        17.4.3. By Indication

        17.4.4. By Distribution Channel

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Drug Class

        17.5.3. By Indication

        17.5.4. By Distribution Channel

    17.6. Drivers and Restraints - Impact Analysis

18. Competition Analysis

    18.1. Competition Dashboard

    18.2. Competition Deep Dive 

        18.2.1. Bayer AG

            18.2.1.1. Overview

            18.2.1.2. Key Financials

            18.2.1.3. Profitability by Market Segments (Product/Channel/Region)

            18.2.1.4. Key Development

            18.2.1.5. SWOT Analysis

            18.2.1.6. Strategy Overview

                18.2.1.6.1. Marketing Strategy

                18.2.1.6.2. Product Strategy

                18.2.1.6.3. Channel Strategy

        18.2.2. GlaxoSmithKline Pharmaceuticals Ltd. 

            18.2.2.1. Overview

            18.2.2.2. Key Financials

            18.2.2.3. Profitability by Market Segments (Product/Channel/Region)

            18.2.2.4. Key Development

            18.2.2.5. SWOT Analysis

            18.2.2.6. Strategy Overview

                18.2.2.6.1. Marketing Strategy

                18.2.2.6.2. Product Strategy

                18.2.2.6.3. Channel Strategy

        18.2.3. Pfizer

            18.2.3.1. Overview

            18.2.3.2. Key Financials

            18.2.3.3. Profitability by Market Segments (Product/Channel/Region)

            18.2.3.4. Key Development

            18.2.3.5. SWOT Analysis

            18.2.3.6. Strategy Overview

                18.2.3.6.1. Marketing Strategy

                18.2.3.6.2. Product Strategy

                18.2.3.6.3. Channel Strategy

        18.2.4. Allergan Plc

            18.2.4.1. Overview

            18.2.4.2. Key Financials

            18.2.4.3. Profitability by Market Segments (Product/Channel/Region)

            18.2.4.4. Key Development

            18.2.4.5. SWOT Analysis

            18.2.4.6. Strategy Overview

                18.2.4.6.1. Marketing Strategy

                18.2.4.6.2. Product Strategy

                18.2.4.6.3. Channel Strategy

        18.2.5. Almirall SA

            18.2.5.1. Overview

            18.2.5.2. Key Financials

            18.2.5.3. Profitability by Market Segments (Product/Channel/Region)

            18.2.5.4. Key Development

            18.2.5.5. SWOT Analysis

            18.2.5.6. Strategy Overview

                18.2.5.6.1. Marketing Strategy

                18.2.5.6.2. Product Strategy

                18.2.5.6.3. Channel Strategy

        18.2.6. Bristol-Myers Squibb 

            18.2.6.1. Overview

            18.2.6.2. Key Financials

            18.2.6.3. Profitability by Market Segments (Product/Channel/Region)

            18.2.6.4. Key Development

            18.2.6.5. SWOT Analysis

            18.2.6.6. Strategy Overview

                18.2.6.6.1. Marketing Strategy

                18.2.6.6.2. Product Strategy

                18.2.6.6.3. Channel Strategy

        18.2.7. Merck & Co., Inc.

            18.2.7.1. Overview

            18.2.7.2. Key Financials

            18.2.7.3. Profitability by Market Segments (Product/Channel/Region)

            18.2.7.4. Key Development

            18.2.7.5. SWOT Analysis

            18.2.7.6. Strategy Overview

                18.2.7.6.1. Marketing Strategy

                18.2.7.6.2. Product Strategy

                18.2.7.6.3. Channel Strategy

19. Assumptions and Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 02: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 03: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 04: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region

Table 05: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 06: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 07: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 08: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

Table 09: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 10: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 11: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 12: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

Table 13: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 14: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 15: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 16: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

Table 17: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 18: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 19: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 20: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

Table 21: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 22: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 23: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 24: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

Table 25: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 26: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 27: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 28: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

Table 29: Middle East and Africa  Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 30: Middle East and Africa  Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 31: Middle East and Africa  Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 32: Middle East and Africa  Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

Table 33: China Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 34: China Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 35: China Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

Table 36: India Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 37: India Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 38: India Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

Table 39: South Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 40: South Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 41: South Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 02: Global Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 03: Global Urinary Tract Infection Treatment Market Absolute $ Opportunity, 2019–2029

Figure 04: Global Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 05: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Drug Class, 2019 – 2029

Figure 06: Global Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 07: Global Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 08: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Indication, 2019 – 2029

Figure 09: Global Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 10: Global Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Figure 11: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2019 – 2029

Figure 12: Global Urinary Tract Infection Treatment Market Analysis by Distribution Channel –2019 & 2029

Figure 13: Global Urinary Tract Infection Treatment Market Analysis by Region–2019 & 2029

Figure 14: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Region, 2019 – 2029

Figure 15: Global Urinary Tract Infection Treatment Market Analysis by Region–2019 & 2029

Figure 16: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 17: North America Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 18: North America Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029

Figure 19: North America Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 20: North America Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 21: North America Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Figure 22: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 23: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 24: Latin America Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029

Figure 25: Latin America Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 26: Latin America Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 27: Latin America Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Figure 28: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 29: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 30: Europe Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029

Figure 31: Europe Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 32: Europe Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 33: Europe Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Figure 34: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 35: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 36: South Asia Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029

Figure 37: South Asia Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 38: South Asia Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 39: South Asia Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Figure 40: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 41: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 42: East Asia Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029

Figure 43: East Asia Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 44: East Asia Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 45: East Asia Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Figure 46: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 47: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 48: Oceania Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029

Figure 49: Oceania Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 50: Oceania Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 51: Oceania Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Figure 52: Middle East and Africa  Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 53: Middle East and Africa  Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 54: Middle East and Africa  Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029

Figure 55: Middle East and Africa  Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 56: Middle East and Africa  Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 57: Middle East and Africa  Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Figure 58: Emerging Countries Market Value Share (2019) 

Figure 59: Emerging Countries Urinary Tract Infection Treatment Market Value (US$ Mn), By Key Countries, 2019-2029

Figure 60: China Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 61: China Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 62: China Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Figure 63: India Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 64: India Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 65: India Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Figure 66: South Africa Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029

Figure 67: South Africa Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029

Figure 68: South Africa Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Urinary Tract Infection (UTI) Treatment Market